Stocktoria
Skye Bioscience, Inc. SKYE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-02-24
Skye Bioscience, Inc. statistics & valuation
Market cap$23.9M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -197.5% | -36.5% | -315.3% | -213.8% | -86.5% |
| Return on equity | -279.3% | -39.0% | 1765.9% | 647.6% | -145.3% |
| Current ratio | 3.30 | 16.32 | 0.84 | 0.74 | 2.46 |
Source: SEC EDGAR filings · CIK 0001516551 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.